Recently, there has been a significant shift in the federal government’s stance on cannabis. For over fifty years, cannabis was classified as a Schedule I drug, indicating a high potential for abuse and no accepted medical value.
However, September marked a considerable change as the Department of Health and Human Services (HHS) recommended to the Drug Enforcement Administration (DEA) that cannabis be reclassified to Schedule III.
This reclassification suggests that cannabis has a moderate to low potential for abuse, an accepted …

